HUTCHMED (LON:HCM) Stock Passes Below 200-Day Moving Average – Here’s Why

HUTCHMED (China) Limited (LON:HCM) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 279.53 ($3.52) and traded as low as GBX 227 ($2.86). HUTCHMED shares last traded at GBX 232 ($2.92), with a volume of 59,463 shares.

HUTCHMED Price Performance

The business’s 50-day moving average is GBX 273.70 and its two-hundred day moving average is GBX 279.53. The company has a market capitalization of £1.98 billion, a P/E ratio of -5,800.00 and a beta of 0.76. The company has a quick ratio of 2.97, a current ratio of 2.81 and a debt-to-equity ratio of 11.78.

About HUTCHMED

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.